Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells.

@article{ElRayes2002CiprofloxacinIC,
  title={Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells.},
  author={Basil F. El-Rayes and Robert Grignon and Naveed Aslam and Olivia Aranha and Fazlul H. Sarkar},
  journal={International journal of oncology},
  year={2002},
  volume={21 1},
  pages={207-11}
}
Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer related deaths in men in the United States. Ciprofloxacin is a relatively non-toxic antibiotic that can be easily administered orally with large volume of distribution and good tissue penetration. Studies from others and our laboratory have recently reported its anti-tumor activity in a variety of human tumor cells. In our current experiment, we studied the effect of ciprofloxacin on a hormone resistant… CONTINUE READING